PATRICK NELSON: Open Payments
NPI 1295067643 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 40 payments from 11 companies in 2025. Trend: 2023 $593 · 2024 $1,004 · 2025 $876
Food & beverage: $821Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $412 |
| Organogenesis Inc. | 7 | $107 |
| ABBVIE INC. | 4 | $75 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| UCB, Inc. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Organon LLC | 5 | $35 |
| Amgen Inc. | 2 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28 |
| Lilly USA, LLC | 1 | $24 |
Products named: TREMFYA, SKYRIZI, Sotyktu, CYGNUS DUAL, Bimzelx, OTEZLA, VIA MATRIX, ILUMYA.
Industry payments across AL — which companies pay providers there.
